Search Results

1-20 of 20 results for subject:Cancer

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

Untitled Adjournment debate

Westminster Hall adjournment debate on the NHS appointments system

Lead member

Patsy Calton

Answering member

Stephen Ladyman

Department

Department of Health

Type

Adjournment debates

Date

14 July 2004

Reference

423 c479-86WH

House

House of Commons

Treasury;Office for National Statistics

To ask Mr Chancellor of the Exchequer, what assessment he has made of the change in the incidence of cancer in each region since the Chernobyl nuclear accident. - Inc tables and text of letter from Len Cook of the Office for National Statistics.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Treasury

Type

Written questions

Status

Answered

Tabled on

5 May 2004

For answer on

12 May 2004

Answered on

12 May 2004

Mrs. Calton: To ask the Chancellor of the Exchequer what assessment he has made of the change in the incidence of cancer in each region since the Chernobyl nuclear accident. [171927] Ruth Kelly: The information requested falls within the responsibility of the National Statistician. I have asked him to reply. Letter from Len Cook to Mrs. Patsy Calton, dated 12 May 2004: As National Statistician, I have been asked to reply to your recent Parliamentary Question concerning what assessment has made of the incidence of cancer in each region since the Chernobyl nuclear accident. The Chernobyl nuclear accident occurred on 28th April 1986. The attached table gives the incidence of all cancers in England, from 1986 to 2000 (the most recent year for which data are available), by Government Office Region. Changes over time in the number of cancers registered are affected by many factors unrelated to the Chernobyl accident. These include historic change in smoking patterns, increased testing and screening for specific cancers (e.g. prostate, breast, cervix), and improved ascertainment by regional cancer registries. Directly age-standardised1 rates per 100,000 population of newly diagnosed cases of all cancers2 to residents3 of England, by Government Office Region, 1986-2000 _________________________________________________________________________________________________. England North East North West Yorkshire and the East Midlands Humber 1986 321 345 335 332 313 1987 328 333 333 334 324 1988 337 344 338 341 324 1989 337 351 344 338 322 1990 339 360 346 343 318 1991 340 353 354 344 333 1992 349 351 360 354 347 West Midlands East of England London South East South West 1986 326 321 308 312 305 1987 328 330 326 323 323 1988 347 338 339 329 334 1989 340 330 342 332 333 1990 345 327 340 336 337 1991 350 321 338 334 335 1992 356 326 347 346 355 England North East North West Yorkshire and the East Midlands Humber 1993 348 360 354 352 350 1994 352 359 374 355 346 1995 353 349 379 354 337 1996 351 373 379 354 354 1997 359 373 368 364 344 1998 357 394 374 360 345 1999 360 395 373 356 353 2000 361 393 375 373 355 West Midlands East of England London South East South West 1993 357 322 336 350 359 1994 346 328 342 352 358 1995 358 337 353 354 347 1996 356 331 341 342 339 1997 349 345 372 359 354 1998 364 335 361 347 351 1999 362 337 351 352 381 2000 361 338 355 355 365 _________________________________________________________________________________________________. 1 Using the European standard population 2 All cancers defined as all malignant cancers excluding non- melanoma skin cancer (International Classification of Diseases Ninth revision (ICD-9) codes 140-208, excluding 173; ICD-10 codes C00-C97, excluding C44) 3 Figures relate to cancers recorded by English cancer registries, where the patient was identified as usually resident in England Source: Office for National Statistics

Date

12 May 2004

Reference

421 c353-4W; 171927

House

House of Commons

Prime Minister

1st supplementary on improving cancer outcomes for disadvantaged groups.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Prime Minister

Prime Minister's questions - 1st Supplementary

Status

Answered

Date

5 May 2004

Reference

420 c1339-40

House

House of Commons

Prime Minister

To ask the Prime Minister, if he will list his official engagements for Wednesday 5th May. (Question not printed).

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Prime Minister

Prime Minister's questions - Lead

Status

Answered

Date

5 May 2004

Reference

420 c1339-40; 170154

House

House of Commons

Dept of Health

Supplementary on delivering high quality oncology care and encouraging men and women to give up smoking.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Oral questions - 1st Supplementary

Status

Answered

Date

23 March 2004

Reference

419 c698

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to publish information on waiting times for treatment of cancers not covered by NHS Cancer Plan targets before 2005; what progress has been made towards meeting the targets for cancer treatment in the NHS Cancer Plan. - Inc...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

5 March 2004

Reference

418 c1157-8W;418 c1173-4W; 157771;157773

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, by what date the National Cancer Research Network expects to have all 300 patients recruited for the SPIRIT trial; what the status is of the SPIRIT trial into a cure for prostate cancer; how many centres have been approved to enter patients...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

25 February 2004

Reference

418 c470W;418 c490W; 154935;154936;154937

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of (a) Government and (b) non-Government spending on (i) all cancer research and (ii) breast cancer research in 2003-04; what proportion of the above is for cancer prevention; and if he will make a statement. - Inc...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

29 January 2004

For answer on

6 February 2004

Answered on

6 February 2004

Mrs. Calton: To ask the Secretary of State for Health what assessment he has made of (a) Government and (b) non-Government spending on (i) all cancer research and (ii) breast cancer research in 2003-04; what proportion of the above is for cancer prevention; and if he will make a statement. [152513] Miss Melanie Johnson: In the NHS Cancer Plan, the government stated its commitment to increasing funds for cancer research so as to play a full part alongside its funding partners. We said that, by 2003, we would be investing an additional £20 million each year in the infrastructure for cancer research and an extra £4 million on prostate cancer research. This new funding would mean that, for the first time, Government (through the Department, the Higher Education Funding Council and the research councils) would match the current investment of the voluntary sector. In June 2002, we confirmed to the House of Commons Science and Technology Committee that Government investment in cancer research had already reached the level of the charities. Nevertheless, we remain committed to investing the extra £24 million, as described in the Cancer Plan. The International Cancer Research Portfolio database at www.cancerportfolio.org contains details of projects supported by cancer research funding organisations in the United Kingdom and the United States. Data submitted by the National Cancer Research Institute includes the research portfolios of the 15 largest Government and charitable funders of cancer research in the UK where the research was active on 1 January 2003. The database can be searched by type of cancer, area of research (including prevention), and funding organisation.

Date

6 February 2004

Reference

417 c1123-4W; 152513

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how much has been allocated by his Department to cancer prevention in each of the last three years; and how much was spent in each year. - Inc no figures.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

20 November 2003

Reference

413 c1364W;413 c1360W; 136731

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will amend the Cancer Patient Information Strategy to ensure that information on (a) diagnosis and (b) treatment is available for all people affected by (i) breast cancer and (ii) cancer in general who want it.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 November 2003

Reference

137454; 413 c575-6W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what funding was available for research into a cure for myeloma in each of the last five years; and if he will make a statement about future funding. - Including figures and fact that recently management of the research supported by these...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

24 June 2003

For answer on

8 July 2003

Answered on

8 July 2003

Mrs. Calton: To ask the Secretary of State for Health what funding was available for research into a cure for myeloma in each of the last five years; and if he will make a statement about future funding. [122028] Miss Melanie Johnson: The main Government agency for research into the causes of and treatments for disease is the Medical Research Council (MRC) which receives its funding from the Department of Trade and Industry via the Office for Science and Technology. The MRCs expenditure on research on myeloma is shown in the table. _________________________________________________________________________________________________. Year £ 1998-99 410,000 1999-2000 390,000 2000-01 360,000 2001-02 420,000 2002-03 not available _________________________________________________________________________________________________. The MRC has also supported two major myeloma studies: Myeloma VII and Myeloma VIII. Because the MRC has changed the way in which information is kept about funding of trials, the figures in the table do not include spend on these two studies. The MRC has recently awarded £1 million to the Myeloma IX trial involving 1,600 patients. This trial will evaluate a number of different therapies and modalities of treatment used and being developed for myeloma, to provide information on their impact on response rates, survival and quality of life. The MRC funds a considerable amount of basic underpinning research which is excluded from site- specific figures. As a guide, the MRC spent £75 million on cancer research in 2001-02. In addition, research classified as undertaken in one site may well have implications in another--leukaemia would be a relevant example in the case of myeloma. The Department of Health meets the national health service support costs of research funded by the MRC and research charities. In 2000-01, an estimated £73.2 million was spent on cancer research through research and development allocations to NHS organisations. Management of the research supported by these allocations is devolved and expenditure at project level is not held centrally by the Department.

Date

8 July 2003

Reference

122028; 408 c780W;408 c777-8W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent assessment he has made of delays in the diagnosis of myeloma. - Inc figures and ref to www.doh.gov.uk/cancerwaits.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 July 2003

Reference

122027; 408 c541W;408 c540-1W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, in which hospitals teenagers with cancer are not treated on wards alongside (a) children and (b) older people.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

109401; 404 c96W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps are being taken to reduce the rate of (a) misdiagnosis and (b) late diagnosis among teenage cancer patients.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

109398; 404 c96W

House

House of Commons

Treasury

To ask Mr Chancellor of the Exchequer, what assessment he has made of the level of access to insurance, pensions and mortgage services among teenagers who are recovering from cancer. - The Treasury has made no assessment of the level of access to financial services among teenagers who are recovering...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Treasury

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

109650; 404 c167W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will list those constituencies which (a) have a Teenage Cancer Trust Unit and (b) do not have a Teenage Cancer Trust Unit. - Includes figure.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 April 2003

Reference

109400; 404 c96W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, whether the findings of the exceptional tracking exercise on the additional investment in cancer services will be published (a) in full and (b) on his Department's website; if his Department will use the findings of the exceptional tracking exercise on the additional...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 March 2003

Reference

400 c989-90W;400 c979W; 99313;99314;99312;99311;99926

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what research projects focusing on (a) the link between physical activity and the development of breast cancer, (b) diet and the development of breast cancer and (c) breast cancer prevention his Department is funding; and if he will make a statement. -...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

18 December 2002

For answer on

13 January 2003

Answered on

13 January 2003

Mrs. Calton: To ask the Secretary of State for Health what research projects focusing on (a) the link between physical activity and the development of breast cancer, (b) diet and the development of breast cancer and (c) breast cancer prevention his Department is funding; and if he will make a statement. [88716] Ms Blears: The Medical Research Council (MRC), which receives its funding from the Department of Trade and Industry via the Office of Science and Technology, is the main agency through which the Government supports research on the causes and treatments of disease, including all types of cancer. The Department of Health contributes to the strategies and priorities of the MRC by meeting the national health service costs of the MRC's research (and of charity funded research). The Department also directly funds research to support policy development in health and social care, and to support effective practice in the NHS. In terms of directly funded research, the Department's main focus is on interventions to promote healthy living, including diet and physical exercise, and on research on breast cancer screening. For example, the Department is funding research projects with the following titles: A health impact assessment of agricultural policy, using the impact on fruit and vegetable consumption as a case study; Reducing inequalities in health and diet: the impact of a food retail development--a pilot study; Field co-ordination in health promotion linked to the Cochrane Collaboration. The Department also funds a programme of work at the cancer screening evaluation unit, which evaluates the effectiveness of screening. Part of this programme includes work on breast cancer screening. There are plans for an observational individual-based study of the efficacy of the breast screening programme. The Department provides joint funding for the age trial, on the effect on breast cancer mortality of annual screening from age 40. Over 75 per cent. of the Department's total expenditure on all health research, including on cancer, is devolved to NHS organisations and details are not routinely collected centrally. Summary information about this research is available on the national research register, which is on the web at www.doh.gov.uk/ research. The Department is a member of the National Cancer Research Institute (NCRI). The recent NCRI report "Strategic Analysis 2002" analysed most of the directly funded research of Government and charity funders. The analyses revealed relatively low sums spent on cancer prevention, which has prompted the NCRI to set up a strategic planning group to look at this area to see what further research may be possible and what extra resources might be needed to bring this about. The Department will be working in partnership with its Government and charity cancer research funding partners to take this work forward.

Date

13 January 2003

Reference

88716; 397 c484-5W;397 c482-3W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS Cancer Plan and the implementation of the NICE guidance do not suffer whilst the structural changes to the NHS become established. - (Holding answer 27 June 2002).

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 July 2002

Reference

389 c416W;389 c415W; 64387

House

House of Commons

MACMILLAN CANCER RELIEF'S CANCER TALK

That this House welcomes Macmillan Cancer Relief's Cancer Talk, an innovative educational initiative to counter common classroom myths and misconceptions about cancer; applauds the cross-party support that Macmillan Cancer Relief's Cancer Talk has secured from the many honourable Members who have kindly issued press releases, written to local schools and...

Primary sponsor

Patsy Calton (Liberal Democrat)

Type

Early day motions

Date

6 March 2002

Reference

947

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher